Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
11 Patents
#497 in San Diego, CA
#6,545 in California
#27,540 in US
#51,831 in the World
Hollis-Eden Pharmaceuticals, Inc.
Forward Citations = 203
16 inventors:
San Diego, CA, United States of America
Hollis-Eden Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 90.9
Forward Citations = 203
Loading Chart...
Loading Chart...
16 inventors (with patents filed for the assignee):
James M Frincke (5 out of 25 patents)
Henry A Lardy (4 out of 24 patents)
Padma Marwah (4 out of 12 patents)
4. Ashok Marwah (4 out of 5 patents)
5. Clarence Nathaniel Ahlem (3 out of 8 patents)
6. William Heggie (2 out of 25 patents)
7. Steven K White (2 out of 21 patents)
8. Richard Trauger (1 out of 2 patents)
9. Christopher Reading (1 out of 5 patents)
10. Dwight Stickney (1 out of 2 patents)
11. Dominick L Auci (1 out of 1 patent)
12. Charles Dowding (1 out of 1 patent)
13. Mei Li (1 out of 1 patent)
14. Theodore M Page (1 out of 2 patents)
15. Luis D Carvalho (1 out of 1 patent)
11 patents:
Company Overview
Hollis-Eden Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for various medical conditions. The company specializes in the research and development of novel compounds aimed at modulating the immune system and addressing unmet medical needs. With a commitment to advancing healthcare, Hollis-Eden leverages its expertise in immunology and related fields to create potential treatments that may improve patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hollis-Eden Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/hollis-eden-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]